Royal Emerald Pharmaceuticals

Royal Emerald Pharmaceuticals is a federally compliant pharmaceutical manufacturer and distributor specializing in pharmaceutical-grade botanical drug substances for medical, scientific, and investigational use. The company's DEA-registered facility is located in California and is licensed as a Schedule I bulk manufacturer, authorized to cultivate, manufacture, analyze, import, export, and distribute controlled botanical substances and their constituents. In addition to medical cannabis, Royal Emerald specializes in the compliant distribution of other novel Schedule I botanical drug substances supporting U.S. research programs and global medical applications. Royal Emerald is purpose-built to operate within FDA cGMP, EU GMP, ISO-aligned quality systems, and international treaty frameworks, serving partners across-Clinical research and investigational drug development -International medical export markets -Academic, government, and institutional research